2023 NYSAM Virtual Conference

Aaron Fox, MD Related Seminars and Products

Dr. Aaron Fox is an Associate Professor of Medicine in the Division of General Internal Medicine at Albert Einstein College of Medicine/Montefiore Medical Center. Dr. Fox is board certified in addiction medicine and internal medicine, and he is the Director of the Bronx Transitions Clinic, which provides a medical home to persons returning from jail or prison. His research involves opioid use disorder treatment in primary care, harm reduction and criminal-legal settings. He completed residency training at Montefiore in Primary Care/Social Medicine in 2007, and he received a Master’s Degree in Clinical Research from Einstein in 2012. He is the president elect for the New York Society of Addiction Medicine.

David Lucas, MSW Related Seminars and Products

Dave Lucas (MSW) is a clinical advisor and social work educator committed to improving practices at the intersection of substance use, public health, and the criminal legal system. Currently, he is a senior advisor at Vital Strategies specializing in the areas of overdose prevention, drug policy, and problem-solving justice. Prior to this role, as a clinical advisor at the Center for Justice Innovation, Dave provided technical assistance to judges, prosecutors, and law enforcement on harm reduction and drug court best practices. Dave also spent a decade providing direct service, as an addiction therapist and treatment court clinical lead at the Centre for Addiction and Mental Health (CAMH). He has also served as an adjunct professor at the University of Toronto, a course director at York University’s School of Social Work, and has published and presented on harm reduction, drug policy, best practices for court-supervised treatment across North America. Before relocating to New York in 2018, Dave spent his last years in Toronto volunteering at the Moss Park Overdose Prevention Site.

TK Rabii, CASAC-T Related Seminars and Products

My name is TK Rabii. My pronouns are he/him and I’m an individual in recovery from substance use disorder and for mental health. I have my CASAC-T and am the current YMSM (Young Men Who Have Sex with Men) Coordinator at In Our Own Voices, Inc, whose mission is to ensure the physical, mental, spiritual, political, cultural and economic survival and growth of LGBTQ+ POC communities. I have experience working for Ellis Medicine for the past 4 years in outpatient day treatment, crisis diversion, case management, and inpatient services, working with individuals with substance use disorders, mental health diagnoses, and developmental disabilities. I currently hold a position on the board of New Choices Recovery Center and co-lead the up-and-coming RCO, RISE (Recovery in Schenectady Every-Day. My work is inspired by own personal recovery journey, a desire to assist individuals in establishing and maintaining a wellness pathway of their choosing, and a hope that we may all live in a world where we authentically and wholeheartedly care about ourselves and others.

Samantha Cleveland, MS, CASAC-AC Related Seminars and Products

Samantha Cleveland currently serves as the Resource Coordinator of the Oswego County Intervention Court program, formally known as the Oswego Opioid Intervention Court. With fifteen years of experience, her professional background includes clinical counseling, quality improvement, project management and case management. In 2011, She achieved a Credentialed Alcoholism Substance Abuse Counselor (CASAC) certification. Samantha holds a Master of Arts in Forensic Psychology from Arizona State University. She earned an Advanced Certificate in Trauma Studies from the State University of New York at Oswego.

Doug Marlowe, JD, PhD Related Seminars and Products

Douglas B. Marlowe, J.D., Ph.D., is a senior scientific consultant for the National Association of Drug Court Professionals (NADCP). Dr. Marlowe is a lawyer and clinical psychologist whose research and practice focus on the effects of drug courts and other rehabilitation programs for persons with substance use disorders involved in the justice system and behavioral treatments for persons with substance use disorders and justice system involvement. He is a Fellow of the American Psychological Association and the College of Physicians of Philadelphia.

Dr. Marlowe has published over 175 journal articles, monographs, books, and book chapters on the topics of correctional rehabilitation, forensic psychology, and treatment of substance use disorders. He is the Editor-in-Chief of the Journal for Advancing Justice, serves on the editorial boards of Criminal Justice & Behavior and the Drug Court Review, and was previously the Editor-in-Chief of the Drug Court Review.

Bridget Dooling, JD Related Seminars and Products

Bridget C.E. Dooling is a Research Professor with the George Washington University Regulatory Studies Center and a Professor of Law (by courtesy) at GW Law.

Previously, she was a deputy branch chief, senior policy analyst, and attorney for the Office of Information and Regulatory Affairs (OIRA) at the U.S. Office of Management and Budget (OMB), where she reviewed draft regulations from FDA, SAMHSA, and other agencies. She also served on the Biden-Harris Transition Team. She is on the editorial board for the Food & Drug Law Journal for FDLI and the Council of the ABA's Administrative Law and Regulatory Practice Section. She is the principal investigator for grants from the Pew Charitable Trusts to study regulatory issues associated with substance use disorder. She was also part of the planning committee for a recent National Academies workshop on the regulation of methadone.

Danielle Russell, PhD Candidate Related Seminars and Products

Danielle Russell holds an AAS from Gateway Community College, and a BS and an MS in Justice Studies from ASU. She is currently a PhD candidate at Arizona State University, where she studies how the criminalization of substances used for personal pleasure has become a key issue and tool for social control, contributing to the ongoing legacy of racialized criminalization and mass incarceration in the U.S.

Having personally experienced many of the harms that impact people who use illicit drugs, she is passionate about mutual aid and working to change the structures that impose harms on the bodies of drug users.  Her research interests are oriented towards community-based participatory research.

Edwin Salsitz, MD, DFASAM Related Seminars and Products

Dr. Edwin A. Salsitz has been an attending physician in the Mount Sinai Beth Israel , Division of Addiction Medicine,  New York City, since 1983, and is an Associate Clinical Professor of Psychiatry at the Mount Sinai School of Medicine.  He is the principal investigator of the Methadone Medical Maintenance (office-based methadone maintenance) research project.  Dr. Salsitz is certified in Addiction Medicine by the American Board of Preventive Medicine, as well as by the Board of Internal Medicine and Pulmonary Disease.  He has published and lectures frequently on addiction medicine topics.

Dr. Salsitz is a course director for ASAM sponsored Buprenorphine and REMS safe opioid prescribing trainings, and is a lead mentor in the PCSS-MAT mentoring program.  He has co-chaired  the ASAM Review Course, the ASAM Common Threads Course, the ASAM State of the Art course and is a reviewer for the Journal of Addiction Medicine and Drug and Alcohol Dependence. He is the chair of the ASAM REMS course on safe and effective prescribing of opioids. Dr. Salsitz was the Co-chair of the ASAM CME committee and Chair of the New York Society of Addiction Medicine CME and Education committee. 

Dr Salsitz teaches addiction medicine at the Icahn School of Medicine at Mount Sinai, to third year medical students, masters of science students, neuroscience PH.D candidates, and psychiatry residents. 

Dr. Salsitz was a founding member of the medical advisory panel, for the New York State Office of Alcohol and Substance Abuse Services.

Dr. Salsitz is the recipient of the 2014 ASAM Annual Award,  the 2018 ASAM Annual Educator of the Year Award, and the 2021 NYSAM Lifetime Achievement Award.

Melanie Maclennan, MD Related Seminars and Products

Dr Melanie MacLennan is a Diplomate of American Board of Addiction Medicine (2015) and  Diplomate of American Board of Family Practice.  She is a 1993 Graduate of SUNY Downstate Medical School and received her Master’s in Public Health in Maternal & Child Health from University of North Carolina at Chapel Hill. (1995)

After residency at UNC Asheville, her Family Medicine practice focused on women’s health ( Abortion care through 16 weeks), particularly for those women living in geographically and socio-economically underserved communities in the Asheville, NC and  the Southern states. 

She is a graduate of Stockton State College with a Bachelor’s Degree in Fine Arts and has a Master’s degree in Photography from California Institute of the Arts.

Dr MacLennan has treated the diseases of addiction in a wide variety of medical settings including working at hospital detoxification programs providing comprehensive evaluations, consultations and medical management of withdrawal.   She has directed  community out-patient opiate and alcohol detox centers and managed multi-disciplinary medical teams to establish best practices and medical management protocols for treating patients with active addiction disorders.  Currently, Dr MacLennan is the Medical Director of the Catch (Consult for Addiction Treatment and Care in Hospitals) at Elmhurst Hospital.

Dr MacLennan takes an integrated approach to the treatment of her addiction patients, including treating the co-occurring disorders of psychiatric diagnosis and trauma related disorders. She is a licensed Buprenorphine provider and has been using medication assisted treatment in her practice for over fifteen years.

Norm Wetterau, MD, FAAFP, DFASAM Related Seminars and Products

Doctor Wetterau was the first graduate of University of Rochester’s Family Medicine Program.

In his rural practice in Dansville and Nundu ,New York he began treating alcohol problems with considerable success and this interest lead to his involvement in ASAM. He headed up the ASAM family medicine interest group and helped  form the STFM addiction group. He helped in the formation of NYSAM where he was its second president and a long term board member. He was involved in the formation of the Addiction Medicine Speciality Board. He was chapter council co-chairman of  ASAM and on the ASAM board. He was involved in three White House Conferences on Addiciton treatment. He was an early prescriber of buprenorphine and has taught many physicians to prescribe this. He was NY State Family Physician of the Year in 1998  and  New York State Association of Rural Health Rural Physician of the Year in 2008  He has taught  residents at the University of Rochester Family Medicine Residency for almost 50 years where he is now Clinical Professor Emeritus. He retired at age 80 in 2022.

Deepika Slawek, MD, MS, MPH Related Seminars and Products

Deepika Slawek, MD, MPH, MS is an Assistant Professor of Medicine at Montefiore Health Systems and Albert Einstein College of Medicine in Bronx, NY in the Division of General Internal Medicine. She is board certified in Infectious Diseases, Addiction Medicine, and Internal Medicine and is the Co-Director of the Montefiore Medical Cannabis Program. Dr. Slawek works to improve long term outcomes in people living with HIV (PLWH) and people who use cannabis for therapeutic purposes in her clinical work and research. Dr. Slawek is the recipient of a K23 award from the National Institute on Drug Abuse to test how different formulations of medical cannabis affect neuropathic pain and inflammation in PLWH in an innovative quasi-experimental study.

Prior to joining Montefiore-Einstein, Dr. Slawek completed her residency training in Primary Care Internal Medicine at Stony Brook University Hospital and her Infectious Diseases Fellowship at New York University/Bellevue Hospital Center. She holds a Masters of Science in Clinical Research Methods from Albert Einstein College of Medicine.

Dan Ciccarone, MD, MPH Related Seminars and Products

Dr. Dan Ciccarone is the Justine Miner Professor in Addiction Medicine, in the department of Family and Community Medicine, at UCSF. He has been principal or co-investigator on numerous NIH sponsored public health research projects including his current Synthetics in Combination (SYNC) study. He is a recognized international scholar on the medical, public health and public policy dimensions of substance use, risk and consequences. He is Associate Editor for the International Journal of Drug Policy and recently edited an IJDP special issue on the “triple wave crisis” of opioids, heroin and fentanyl in the US. He consults for numerous private and public entities including the ONDCP, CDC and FDA.

Lamia Haque, MD, MPH Related Seminars and Products

Lamia Haque, MD, MPH is an Assistant Professor in the Department of Internal Medicine - Section of Digestive Diseases at Yale School of Medicine as well as a Core Faculty Member in the Yale Program in Addiction Medicine and a NIDA-K12 Scholar in the Yale Drug use, Addiction, and HIV Research Scholars program. She received her medical degree from the Warren Alpert Medical School of Brown University and completed her residency in Internal Medicine as well as fellowship training in Addiction Medicine, Digestive Diseases, and Advanced/Transplant Hepatology at Yale School of Medicine. As a clinician-scientist, addiction medicine specialist, and hepatologist, her scholarly and educational efforts have focused on optimizing outcomes for individuals with liver diseases and addiction, specifically alcohol-associated liver disease and chronic hepatitis C infection. In addition to her research, she has established the Yale Clinic for Alcohol and Addiction Treatment in Hepatology where patients receive integrated care for liver disease and addiction and has worked with the American Association for the Study of Liver Diseases to organize an addiction medicine curriculum for liver care providers.

Shannon Smith-Bernadin, PhD, RN, CNL Related Seminars and Products

A registered nurse by trade, Dr. Smith-Bernardin is a nurse consultant, researcher, educator, and health care practitioner. She has worked in homeless health care since 2006, with expertise in alcohol use and public intoxication, alcohol harm reduction including managed alcohol programs, medical respite/ recuperative care, and street-based homeless engagement teams. Shannon’s primary focus is on the utilization of sobering centers in lieu of the emergency department and jail for adults intoxicated in public. Building from her clinical, research, and administrative nursing experience , Dr. Smith-Bernardin’s work currently encompasses three roles emphasizing health services research, program development, and policy efforts. First, she is assistant professor at UCSF School of Nursing specializing in alcohol use disorders, sobering center utilization, and homeless-related research. She is funded through a five-year NIAAA grant investigating emergency medical and sobering care collaborations in the care of acute alcohol intoxication. Second, Shannon is co-founder and the first board president of the National Sobering Collaborative, a 501(c)3 nonprofit aimed at identifying and developing best practices, standards, and education towards the use of sobering centers for the care of individuals with harmful substance use. Lastly, she consults in the development of related programs for communities throughout the United States and internationally.

Dr. Smith-Bernardin holds a doctorate from University of California-San Francisco School of Nursing, a Master’s from Western University of Health Sciences, and a Bachelor’s degree from Dartmouth College.

Timothy Wiegand, MD, FACMT, FAACT, DFASAM Related Seminars and Products

Timothy J. Wiegand, MD, FACMT, FAACT, DFASAM is Program Director for the URMC Addiction Medicine Fellowship Program, and the Medical Director for Huther Doyle, an addiction services provider in Rochester, New York, where he works in a collaborative model providing a variety of services for patients with substance use disorders, and serves as facilitator for their Project ECHO program on Pain, Opioid Prescribing and Addiction. In addition to ED, hospital and clinic work treating drug exposures, intoxication, withdrawal and assisting with pain management for patients maintained on medications for opioid use disorder (MOUD) in the ED, hospital and perioperative setting, Dr. Wiegand is involved with medical education and research in toxicology and addiction.

Paul Wax, MD, FACMT Related Seminars and Products

Dr. Wax is the Executive Director of the American College of Medical Toxicology (ACMT) and an Adjunct Clinical Professor at UT Southwestern Medical School in Dallas. Dr. Wax received his B.A from Dartmouth College, his M.D. from the Mount Sinai School of Medicine, his Emergency Medicine residency training at UCLA, and his Medical Toxicology fellowship training at New York University.  He is Board-certified in both Medical Toxicology and Emergency Medicine. In 2010 Dr Wax co-founded ACMT’s Toxicology Investigators Consortium, known as ToxIC. A multicenter research consortium and patient registry, ToxIC currently receives funding from NIH, CDC, and FDA and in recent years has focused on the fentanyl epidemic. In 2019 Dr. Wax received the Career Achievement Award in Medical Toxicology from the American College of Medical Toxicology.

Barry Logan, PhD Related Seminars and Products

Dr. Barry Logan is Executive Director at the non-profit Center for Forensic Science Research and Education (CFSRE) at the Fredric Rieders Family Foundation in Willow Grove, Pennsylvania.   He is also Chief Scientist at NMS Labs in Horsham PA, where he leads a team of forensic toxicologists and certifying scientists.  He holds academic appointments at Arcadia, Thomas Jefferson and Indiana Universities in the United States.

Dr. Logan is a Fellow of the American Board of Forensic Toxicologists (ABFT), and has over 200 publications and has made over 700 presentations in forensic toxicology and analytical chemistry, including work on the effects of illicit and prescription drugs on drivers, and drug caused and related death.  His current research priorities are focused on new drug trends, the opioid crisis, rapid reporting of drug mortality data, and the analytical and interpretive toxicology and chemistry of novel psychoactive substances, founding www.NPSDiscovery.org in 2018.

Dr. Logan’s contributions to the field of toxicology were recognized in 2021 by the International Association of Forensic Toxicologists (TIAFT) presentation of the Alan Curry Lifetime Career Achievement Award.

Ross Sullivan, MD, FACMT Related Seminars and Products

Dr. Sullivan completed his medical school education at SUNY Upstate Medical University in Syracuse, NY. After, he entered and finished a residency in Emergency Medicine at the same hospital.  Dr. Sullivan then completed a medical toxicology fellowship at the SUNY Upstate Poison Control Center and SUNY Upstate Emergency Department. Dr. Sullivan is also board certified in Addiction Medicine. Dr. Sullivan is the Executive Medical Director of Helio Health (a community not-for-profit that offers substance use and psychiatric treatment), as well as the director of the medical toxicology fellowship and inpatient addiction medicine at SUNY Upstate Hospital. He also is the director of the Upstate Emergency Medicine Opioid Bridge Clinic; a program initiating buprenorphine in the ED with prompt referral to an ED based clinic .

Dr. Sullivan has co-authored several publications related to overdose and addiction, including “Cardiac conduction disturbance after loperamide abuse”, “Synthetic Cannabinoid Withdrawal”, “Baclofen overdose mimicking brain death”, “A randomized usability assessment of simulated naloxone administration by community members,” and recently “Bridge clinic buprenorphine program decreases emergency department visits”. Dr. Sullivan is currently a member of the Medical Advisory Panel to NY-OASAS (Office of Addiction Services and Support), the NY-DOH buprenorphine work group, as well as the Treasurer and Board Member of NYSAM (New York Society of Addiction Medicine)

Kim Aldy, DO, MS, MBA Related Seminars and Products

Dr. Kim Aldy earned her medical degree at the University of North Texas Health Science Center in Fort Worth, Texas. She completed residency in emergency medicine at Western Michigan University in Kalamazoo, Michigan, and a medical toxicology fellowship at the University of Texas at Southwestern Medical Center in Dallas, Texas.

Dr. Aldy now serves as the Program Director of the Toxicology Investigator's Consortium, the multicenter toxicosurveillance and research network built through the American College of Medical Toxicology. She has also maintained an academic and clinical affiliation with the Departments of Emergency Medicine and Medical Toxicology at Baylor University Medical Center in Dallas, Texas.

Jeanmarie Perrone, MD, FACMT Related Seminars and Products

Jeanmarie Perrone, MD is a Professor in the Department of Emergency Medicine and the founding Director of the Penn Center for Addiction Medicine and Policy at the University of Pennsylvania.  Dr. Perrone leads a program for the treatment of Opioid Use Disorder in the emergency department and a virtual telehealth bridge clinic (CareConnect) for low barrier access to medications for opioid use disorder. She has advocated at the state and national level for enhancing equitable care for substance use and is a lead co-investigator in a 20 site NIDA sponsored RCT of ED buprenorphine. Dr. Perrone is boarded in emergency medicine, medical toxicology and addiction medicine.

Paul Joudrey, MD, MPH Related Seminars and Products

Dr. Joudrey is an Assistant Professor in the Division of General Internal Medicine at the University of Pittsburgh School of Medicine. Certified as a General Internist and Addiction Medicine specialist, Dr. Joudrey provides primary care, addiction medicine, and harm reduction services within outpatient and community settings. His research focuses on identifying factors impacting addiction treatment access and outcomes across urban and rural communities and developing, evaluating, and scaling interventions tailored to community needs to improve the health of people who use drugs. This includes research to expand access to patient centered methadone treatment for opioid addiction.

Marco Barber Grossi, MD Related Seminars and Products

Marco Barber Grossi, MD is a second-year resident in Internal Medicine-Primary Care at NYU Langone/Bellevue Hospital. He received his medical degree from Columbia University Vagelos College of Physicians and Surgeons where he volunteered in a student-run clinic serving patients who used drugs. In residency, he has enjoyed working in a buprenorphine clinic and a clinic for patients with complex medical and psychiatric needs who are unstably housed. He hopes to continue to work with these populations after residency.

Melissa Chiang, MD Related Seminars and Products

Melissa Chiang, MD is the Primary Care Track Chief Resident at NYU Grossman School of Medicine for the 2022-2023 academic year. She completed her undergraduate training at Columbia University, where she graduated magna cum laude with a major in neuroscience and behavior. After taking a gap year to work at Health Leads, a nonprofit organization aimed at addressing systemic barriers to health and decreasing inequity in medicine, she attended Columbia University’s College of Physicians and Surgeons for medical school. While there, her love of primary care grew through her involvement with the Daniel Noyes Brown Primary Care Scholars program and the Columbia-Harlem Homeless Medical Partnership, a student-run free clinic that provides primary care services to the homeless and uninsured community of West Harlem. She then continued her primary care training at NYU Grossman School of Medicine, where she was drawn to Bellevue’s service-driven mission. She hopes to continue caring for underserved patients in urban areas throughout her career.

Anna Fagbemi, BS Related Seminars and Products

Anna Fagbemi is a native New Yorker from Long Island and a 3rd-year medical student at the City University of New York (CUNY) school of medicine. She graduated magna cum laude with a bachelors degree in biomedical sciences from the Sophie-Davis program at the City College of New York. This competition has sparked her further study and research into the complication of Alcohol Use disorder associated with gastric weight loss surgeries. Apart from patient advocacy, she is involved in a mentorship program for high school and pre-med students. Outside of scholarly pursuits, she enjoys playing multiple musical instruments, sports and singing.

Mathew Kladney, MD Related Seminars and Products

Mat Kladney is an internist based at Bellevue Hospital.  When not providing clinical care as a primary care doctor and hospitalist, Mat works at the site-PI for RDD/CTN100, a clinical research trial trying to discover how best to care for people with OUD using various medication and psychosocial interventions.  If you see Mat outside of the hospital, you’ll likely find him playing soccer, riding his bike, or knitting a hat.

Eric Kutscher, MD Related Seminars and Products

Eric Kutscher MD is a Fellow in Addiction Medicine at NYU Grossman School of Medicine. He completed his undergraduate degree at Columbia University in History of Public Health and African Studies, and obtained his medical degree from Weill Cornell Medical College. Dr. Kutscher finished an intern year in pediatrics at Mass General for Children, before returning to NYC for residency in internal medicine-primary care at NYU Langone Health/Bellevue Hospital. He has a passion for using medical education reforms to address health disparities through creating a generation of physicians better equipped to care for marginalized and underserved communities, previously developing an elective course Community Perspectives in Medicine and most recently serving as co-director of the Block for Addiction Medicine for the NYU Internal Medicine-Primary Care residency program. His research interests involve the overlap of substance use disorders with vulnerable populations, particularly the LGBT community and previously incarcerated individuals.

Kara Ryan, MD Related Seminars and Products

Kara Ryan, MD is a third-year internal medicine-primary care resident and rising ambulatory chief resident at New York Presbyterian-Weill Cornell Medical Center. She is a graduate of Tufts University School of Medicine. Her interests include incorporating addiction medicine into primary care as well as integrating addiction training into medical school and residency curricula. Following residency, Dr. Ryan plans to pursue a fellowship in addiction medicine.

Kelly Ramsey, MD, MPH, MA, FACP, DFASAM Related Seminars and Products

Addiction Medicine Physician

Kelly S. Ramsey, MD, MPH, MA, FACP, FASAM is a board certified internal medicine and addiction medicine physician who has treated substance use disorder since 2004. She worked as Medical Director of an academic center-based OTP in the South Bronx before working for nearly a decade for a large FQHC in the Hudson Valley where she created and grew a MAT program for OUD and AUD to 10 sites and 1500 patients. Most recently, Dr. Ramsey worked as the Chief of Medical Services at the NYS Office of Addiction Services and Supports (OASAS).

Dr. Ramsey has provided expert advice to the New York State Department of Health AIDS Institute, serving on numerous committees for about 15 years as the Co-Chair of the HIV Quality of Care Advisory Committee (QAC) until December 2020; and, until starting at OASAS in June 2020, Vice-Chair of the Substance Use Guidelines Committee for the HIV Clinical Practice Guidelines (a collaboration with Johns Hopkins University) and Co-Chair of the Office of Drug User Health’s NYS Buprenorphine Advisory Workgroup.

Dr. Ramsey was the recipient of the New York State Commissioner’s Special Recognition Award for contributions to drug user health in NYS in December 2018. Dr. Ramsey was the Distinguished Contributions to Behavioral Medicine Award Recipient, awarded by the American College of Physicians (ACP)in April 2023. Dr. Ramsey was awarded the Case Western Reserve University School of Medicine Special Medical Alumni Board Award in October 2023.

Dr. Ramsey is the President for the NYSAM BOD. In addition, she currently serves as Region I Director on the ASAM Board of Directors. 

Linda Wang Related Seminars and Products

Clinical Education Initiative, Hepatitis C and Drug User Health Center of Excellence

Linda Wang, MD is a general internist and addiction medicine specialist who cares for people who use drugs at the REACH Program at Mount Sinai, where she also directs the buprenorphine treatment program. She received her medical degree from the Icahn School of Medicine at Mount Sinai and completed internal medicine residency and chief residency in the Primary Care and Social Internal Medicine Program at Montefiore Medical Center in the Bronx. She is the Medical Director for the Mount Sinai Hepatitis C and Drug User Health Center of Excellence, which is funded by the New York State Department of Health AIDS Institute. She is the Education and Program Committee Chair for the New York Society of Addiction Medicine. She is an active clinician educator who is interested in expanding access to substance use disorder treatment, providing stigma-free care for people who use drugs, and training current and future clinicians in drug user health.

Katherine Mullins, MD, AAHIVS Related Seminars and Products

Katherine Mullins MD, AAHIVS is the Associate Medical Director of the Sunset Terrace Clinic, where she practices addiction medicine, HIV medicine, and primary care. She is also the Assistant Medical Director of Addiction Medicine for her FQHC network, the Family Health Centers at NYU Langone, and a Clinical Assistant Professor for the NYU Grossman School of Medicine. Previously, she completed her Primary Care/Social Internal Medicine Residency and Addiction Medicine Fellowship at Montefiore Medical Center. She is passionate about integrating harm reduction principles into medical education and developing primary care systems that support people who use drugs or have substance use disorders.

Tiffany Lu, MD, MS Related Seminars and Products

Tiffany Lu, MD, MS is an Associate Professor of Medicine and Psychiatry at Albert Einstein College of Medicine in Bronx, New York. She is currently Associate Director of Addiction Services at New York City Health & Hospitals/Jacobi where she serves as medical director of the hospital's opioid treatment program and leads addiction care and education initiatives across the safety net health system.
Prior to joining Jacobi, Dr Lu was the Medical Director of Montefiore's Buprenorphine Treatment Network, where she led primary care-based opioid use disorder treatment across 7 community health centers. She also founded the Addiction Medicine "Bridge Clinic” to provide low-threshold care for people with substance use disorders. Dr. Lu was Principal Investigator of a federal grant to expand addiction education for medical students and residents and municipal contracts to integrate nurse care management for buprenorphine treatment.
Dr. Lu graduated from UCSF School of Medicine and completed her Internal Medicine Residency at Massachusetts General Hospital. She holds a Masters of Science in Clinical Research Methods from Albert Einstein College of Medicine. She is board certified in Internal Medicine and Addiction Medicine. In addition, Dr Lu is active with the American Society of Addiction Medicine as member of the Quality Improvement Council and Education Chair for the New York Chapter.